2006
DOI: 10.1016/j.tig.2006.08.003
|View full text |Cite
|
Sign up to set email alerts
|

Switching trypanosome coats: what's in the wardrobe?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
133
0
2

Year Published

2008
2008
2016
2016

Publication Types

Select...
4
3
2

Relationship

0
9

Authors

Journals

citations
Cited by 171 publications
(135 citation statements)
references
References 49 publications
0
133
0
2
Order By: Relevance
“…They proliferate as extracellular parasites in the bloodstream of their mammalian host and can, later on, cross the blood-brain barrier to provoke severe neurological symptoms that are fatal in the absence of treatment . Trypanosomes evade the host immune response by a sophisticated process of antigenic variation involving a dense surface coat of a single type of protein called variant surface glycoprotein (Berriman et al, 2005;Cross, 1975;Taylor and Rudenko, 2006). There is no vaccine and treatments are difficult to administer in rural areas and can provoke severe side effects .…”
Section: Introductionmentioning
confidence: 99%
“…They proliferate as extracellular parasites in the bloodstream of their mammalian host and can, later on, cross the blood-brain barrier to provoke severe neurological symptoms that are fatal in the absence of treatment . Trypanosomes evade the host immune response by a sophisticated process of antigenic variation involving a dense surface coat of a single type of protein called variant surface glycoprotein (Berriman et al, 2005;Cross, 1975;Taylor and Rudenko, 2006). There is no vaccine and treatments are difficult to administer in rural areas and can provoke severe side effects .…”
Section: Introductionmentioning
confidence: 99%
“…The strategy of varying antigen presentation over time is found in diverse pathogens, including protozoa, viruses, helminths and bacteria (Barbour, 1987;Centurion-Lara et al, 2004;Diamond, 2003;Kline et al, 2003;Taylor & Rudenko, 2006;Zhang et al, 1997). In order to produce variant antigens, the pathogen typically can produce variant genes de novo (e.g.…”
Section: Introductionmentioning
confidence: 99%
“…Antigenic variants are generated by gene conversion in which an intact hypervariable region (HVR) or an HVR oligonucleotide segment is recombined from nonexpressed chromosomal loci into the major surface protein-2 (Msp2) expression site (9,10). This mechanism is very similar to that used by African trypanosomes in which the complete (or nearly complete) variable surface glycoprotein (VSG) coding sequences or oligonucleotide segments are recombined into an expression site to generate a new VSG variant (11). Importantly, A. marginale has a relatively small genome (1/20th the size of Trypanosoma brucei), facilitating the sequencing of the complete repertoire of chromosomal msp2 donor alleles in each of multiple strains (9,12,13), data required to test the hypothesis but not yet available for other highly antigenically variable vector-borne pathogens such as Babesia, Plasmodium, and Trypanosoma (14 -17).…”
mentioning
confidence: 99%